Related Experiment Video

Updated: Jun 3, 2026

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
13:48

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound

Published on: April 21, 2023

[Endovascular treatment for renal artery stenosis]

Masato Nakamura1

  • 1Division of Cardiovascular Medicine, Ohashi Medical Center, Toho University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|March 11, 2011
PubMed

Insights

Atherosclerosis causes most renal artery stenosis, a key factor in secondary hypertension. Identifying patients who benefit from renal artery stenting is crucial for effective treatment.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Hypertension Research

Context:

  • Atherosclerosis is the primary cause of renal artery stenosis (RAS), accounting for 90% of cases.
  • RAS can lead to secondary arterial hypertension through mechanisms including renin-angiotensin system activation.
  • Despite high technical success rates, renal artery stenting outcomes for hypertension remain inconsistent.

Purpose:

  • To highlight the clinical need for accurate predictors to guide renal artery stenting indications.
  • To identify key factors influencing the decision-making process for RAS revascularization.

Summary:

  • Renal artery stenosis, predominantly atherosclerotic, contributes significantly to secondary hypertension.
  • While stenting is often successful, its impact on hypertension control is variable.
  • Current decision-making for stenting involves assessing stenosis severity, patient symptoms, and procedural risks.

Impact:

  • Improved patient selection for renal artery stenting can optimize hypertension management.
  • Better identification of suitable candidates may lead to more consistent clinical outcomes.
  • This research underscores the importance of personalized medicine in treating complex cardiovascular and renal conditions.

Related Concept Videos

Imaging Studies VII: Vascular Imaging01:19

Imaging Studies VII: Vascular Imaging

DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...